Springe direkt zu Inhalt

Article online on Erlotinib resistance in an EGFR Activating Mutated NSCLC

News from Mar 30, 2021

The manuscript “Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line” by Saafan, Alahdab, Michelet et al. has been accepted in the journal Cells and is available online now.

1 / 2